Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to $65.7 million.

  • ProPhase Labs' Liabilities and Shareholders Equity fell 2843.54% to $65.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.1 million, marking a year-over-year decrease of 3984.02%. This contributed to the annual value of $63.2 million for FY2024, which is 3124.98% down from last year.
  • According to the latest figures from Q3 2025, ProPhase Labs' Liabilities and Shareholders Equity is $65.7 million, which was down 2843.54% from $42.0 million recorded in Q2 2025.
  • ProPhase Labs' 5-year Liabilities and Shareholders Equity high stood at $99.7 million for Q1 2022, and its period low was $42.0 million during Q2 2025.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $90.0 million (2024), whereas its average is $82.8 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 61995.28% in 2021, then crashed by 5512.18% in 2025.
  • ProPhase Labs' Liabilities and Shareholders Equity (Quarter) stood at $89.3 million in 2021, then fell by 1.84% to $87.6 million in 2022, then increased by 4.88% to $91.9 million in 2023, then plummeted by 31.25% to $63.2 million in 2024, then increased by 3.96% to $65.7 million in 2025.
  • Its Liabilities and Shareholders Equity was $65.7 million in Q3 2025, compared to $42.0 million in Q2 2025 and $50.1 million in Q1 2025.